• Economy
  • Investing
  • Editor’s Pick
  • Stock
Keep Over Tradings
Stock

Buffett Indicator hits 232%: is a US stock market crash coming?

by April 13, 2026
by April 13, 2026

There is a peculiar moment in every great valuation cycle where the data stops being abstract and starts being personal.

For the US stock market, that moment may be now, as one of the bluntest and most time-tested measures of aggregate market valuation is flashing red. And it is sitting there against a backdrop of slowing growth, geopolitical disorder, and a structural unravelling of the very thesis that inflated it.

The math doesn’t lie

The Buffett Indicator divides the total market capitalisation by GDP.

At 106%, its long-run mean, stocks are fairly pricing the productive capacity of the underlying economy.

But at its current 232%, they are pricing in a version of the future that must be exceptional — not just good, not just resilient, but exceptional.

That future requires compounding AI-driven productivity gains, sustained corporate margin expansion, and a soft landing that keeps consumers spending and rates palatable. All three simultaneously. The margin of error is essentially zero.

Meanwhile, Q4 GDP growth was revised down to 0.5% — from an original 1.4% estimate. This is a strong signal that the real economy, the denominator in Buffett’s equation, is softening precisely when the numerator had been pushing to record highs.

This is the valuation trap in its purest form.

Prices are racing ahead of fundamentals until the gap becomes structurally unstable.

The concentration illusion

The headline overvaluation is real, but the story beneath it is more nuanced and, in some ways, more interesting.

To this day, seven companies — Nvidia, Apple, Google, Microsoft, Amazon, Broadcom, and Meta — represent 33.5% of the entire S&P 500. The other 493 companies share what remains.

This is a basket with seven stones in it and 493 pebbles. When those seven stocks move, the index moves. When they don’t, it stagnates regardless of the breadth below.

However, several of those seven have already taken significant punishment. Microsoft is down 28% over the past six months.

Meta has shed 12%.

On a forward earnings basis, some of these names now trade at or below broader market multiples — a remarkable development for companies that commanded 30x, 35x, and 40x premiums during the AI euphoria of 2023 and 2024.

So the paradox is that the index looks expensive, but the largest components of it, increasingly, do not.

That divergence is the central tension every investor needs to resolve before making an allocation decision.

The exceptionalism premium is expiring

Layer onto this the erosion of the American exceptionalism trade, and the picture sharpens further. Since October 2025, the S&P 500’s valuation premium over Canadian and global ex-US equities has narrowed to its lowest level since 2020.

US stocks underperformed both in 2025 and continue to do so in 2026.

The thesis that drove a decade-long premium — that American tech dominance, consumer resilience, and monetary credibility justified perpetually higher multiples — is being actively repriced by global capital.

This repricing is not irrational panic.

It is a rational response to three simultaneous pressures: tariff policy uncertainty disrupting earnings visibility, AI capex cycles that are beginning to demand revenue justification rather than just enthusiasm, and geopolitical risk in the Strait of Hormuz reintroducing the kind of energy-price volatility that feeds directly into inflation and rate expectations.

The Goldman Sachs resource reality thesis is that the physical world is repricing as critical mineral supply fails to match electrification and AI demand.

This adds a further input cost layer that US corporate margins have not yet fully absorbed.

The verdict

The US market is overvalued at the index level.

The Buffett Indicator at 232%, GDP growth at 0.5%, and a narrowing exceptionalism premium all point in the same direction.

But overvalued and uninvestable are not synonyms.

The more precise observation is that the index is expensive, but the index is not the market.

Within it, the most punished of the Magnificent Seven are approaching levels where the risk-reward calculates more honest.

Outside it, in European industrials, emerging market resource plays, and defence-linked supply chains, the Goldman thesis on structural chokepoints offers a compelling alternative to US large-cap beta exposure.

The bottom line for investors today is uncomfortable but clarifying. Passive exposure to the S&P 500 at these levels is essentially a leveraged bet on a specific and demanding macro outcome — one where growth reaccelerates, AI monetisation arrives on schedule, and geopolitical friction remains contained.

That bet may still pay off. But it is no longer the low-risk trade it was sold as.

The post Buffett Indicator hits 232%: is a US stock market crash coming? appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Chinese AI startup StepFun to drop offshore structure for IPO
next post
Morgan Stanley pulls plug on Kering stock as Gucci woes deepen

Related Posts

Intel stock is in a parabolic move, and...

April 13, 2026

Revolution Medicines surges 38% on pancreatic cancer breakthrough

April 13, 2026

IREN stock analysis amid CoreWeave, Nebius market share...

April 13, 2026

Here’s why Nio stock may jump 20% to...

April 13, 2026

Soaring Lumentum stock gets overbought as Wyckoff points...

April 13, 2026

TLT and VGLT ETFs shed billions as US...

April 13, 2026

Tesla stock is beating the broader market today:...

April 13, 2026

SanDisk jumps 7% on Nasdaq 100 entry as...

April 13, 2026

Why is Goldman Sachs stock falling despite blowout...

April 13, 2026

Palantir stock rebounds as Cathie Wood buys, Trump...

April 13, 2026

Recent Posts

  • Can Trump’s Maritime Plan Save America’s Struggling Shipyards?
  • Trump’s Greatest ‘Art of the Deal’
  • Intel stock is in a parabolic move, and a rare pattern points to a surge to $82
  • Revolution Medicines surges 38% on pancreatic cancer breakthrough
  • IREN stock analysis amid CoreWeave, Nebius market share gains

    Master Your Money – Sign Up for Our Financial Education Newsletter!


    Ready to take your financial knowledge to the next level? Our newsletter delivers easy-to-understand guides, expert advice, and actionable tips straight to your inbox. Whether you're saving for a dream vacation or planning for retirement, we’ve got you covered. Sign up today and start your journey to financial freedom!

    Recent Posts

    • Can Trump’s Maritime Plan Save America’s Struggling Shipyards?

      April 13, 2026
    • Trump’s Greatest ‘Art of the Deal’

      April 13, 2026
    • Intel stock is in a parabolic move, and a rare pattern points to a surge to $82

      April 13, 2026
    • Revolution Medicines surges 38% on pancreatic cancer breakthrough

      April 13, 2026
    • IREN stock analysis amid CoreWeave, Nebius market share gains

      April 13, 2026
    • Here’s why Nio stock may jump 20% to $8 in this bull run

      April 13, 2026

    Editors’ Picks

    • 1

      Sandisk’s epic rally: can memory boom push stock to $1,250?

      April 9, 2026
    • 2

      Emerging markets see biggest outflows since 2020 amid Asia sell-off

      April 8, 2026
    • 3

      Evening digest: Iran truce strains; Meta jumps as oil, bitcoin move

      April 8, 2026
    • 4

      AMD stock jumps 4% as ceasefire rally and AI demand fuel optimism

      April 8, 2026
    • 5

      Kospi slips as Iran’s Hormuz gambit puts Asian markets back on edge

      April 9, 2026
    • 6

      Alibaba stock plunges 3% after Jefferies cut: time to sell BABA?

      April 9, 2026
    • 7

      Levi’s sales get Carolyn Bessette ‘Love Story’ boost; stock up 12%

      April 8, 2026

    Categories

    • Economy (7)
    • Editor’s Pick (7)
    • Stock (118)
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: keepovertrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 keepovertrading.com | All Rights Reserved

    Keep Over Tradings
    • Economy
    • Investing
    • Editor’s Pick
    • Stock
    Keep Over Tradings
    • Economy
    • Investing
    • Editor’s Pick
    • Stock
    Disclaimer: keepovertrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 keepovertrading.com | All Rights Reserved

    Read alsox

    US ETF AUM to surpass $25 trillion...

    April 9, 2026

    Dow Jones falls 260 points, indexes mixed...

    April 10, 2026

    These 3 stocks reporting next week have...

    April 11, 2026